Australasian Leukaemia and Lymphoma Group
5 clinical trials · Sponsor
◉ Watch Australasian Leukaemia and Lymphoma Group
| Record | Firm | Date |
|---|---|---|
| A Study Comparing a New Drug (Surovatamig) With Standard Radiotherapy With or Without Rituximab in Adults With Limited Stage Nodal Follicular Lymphoma (NCT07736950) | Australasian Leukaemia and Lymphoma Group | 2027-01-12 |
| Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL (NCT06287398) | Australasian Leukaemia and Lymphoma Group | 2023-12-11 |
| A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure. (NCT05833763) | Australasian Leukaemia and Lymphoma Group | 2023-10-12 |
Track Australasian Leukaemia and Lymphoma Group automatically
Every clearance here is in the API, with alerts when new ones post.